968954a.jpg

Click image to watch video

Presented by:

  • Stevin George,Associate, Sheppard Mullin
  • John Fowle, CFO, Akerna
  • Scott Greiper, President, Viridian Capital Advisors, LLC.
  • Mina Guiahi, former CFO, The Pharm / Sunday Goods
  • Morgan Paxhia, Co-founder & Managing Director, Poseidon Investment Management

About

JThe worldwide COVID-19 pandemic has resulted in unprecedented volatility in the M&A space. The cannabis and hemp industries have not been spared. What impact has the pandemic had on M&A evaluation? What specific trends are emergent with regards to cannabis and hemp-related deals? What are the opportunities and risks for legacy and new investors? These questions and more will be answered in a webinar discussion with leading industry thought leaders, who will offer insights on where cannabis and hemp M&A has been, where it is currently, and, as best we can predict, where it is going in the age of COVID-19.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.